Cargando…

Association between Obstetric Complications and Intravitreal Anti-Vascular Endothelial Growth Factor Agents or Intravitreal Corticosteroids

This nationwide population-based cohort study aimed to describe the use of intravitreal injections (IVTs) of anti-vascular endothelial growth factor (anti-VEGF) agents and corticosteroids in pregnant women in France and to report on the incidence of obstetric and neonatal complications. All pregnant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ben Ghezala, Inès, Mariet, Anne-Sophie, Benzenine, Eric, Bardou, Marc, Bron, Alain Marie, Gabrielle, Pierre-Henry, Baudin, Florian, Quantin, Catherine, Creuzot-Garcher, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501719/ https://www.ncbi.nlm.nih.gov/pubmed/36143159 http://dx.doi.org/10.3390/jpm12091374

Ejemplares similares

Topical Antibiotic Prophylaxis and Intravitreal Injections: Impact on the Incidence of Acute Endophthalmitis—A Nationwide Study in France from 2009 to 2018
por: Baudin, Florian, et al.
Publicado: (2022)

Mid-Term Impact of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure
por: Hannappe, Marc-Antoine, et al.
Publicado: (2022)

Bilateral acute macular neuroretinopathy in a young woman after the first dose of Oxford–AstraZeneca COVID-19 vaccine
por: Gabrielle, Pierre-Henry, et al.
Publicado: (2022)

Plasma Fatty Acids Pattern and Dry Eye Disease in the Elderly: The Montrachet Population-Based Study
por: Seydou, Alassane, et al.
Publicado: (2022)

Cystoid Macular Edema after Rhegmatogenous Retinal Detachment Repair with Pars Plana Vitrectomy: Rate, Risk Factors, and Outcomes
por: Merad, Malik, et al.
Publicado: (2022)

IMPACT study: Impact of adherence to anti‐VEGF intravitreal injections for macular disease during COVID 19‐related confinement in France
por: Hurand, Victoire, et al.
Publicado: (2022)

Mobile Telemedicine Screening for Diabetic Retinopathy Using Nonmydriatic Fundus Photographs in Burgundy: 11 Years of Results
por: Charlot, Anthony, et al.
Publicado: (2022)

Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant
por: Baillif, Stéphanie, et al.
Publicado: (2022)

Comparative Effectiveness of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Managing Neovascular Age-Related Macular Degeneration: A Meta-Analysis
por: Matonti, Frédéric, et al.
Publicado: (2022)

Repeatability and Reproducibility of Retinal Fractal Dimension Measured with Swept-Source Optical Coherence Tomography Angiography in Healthy Eyes: A Proof-of-Concept Study
por: Arnould, Louis, et al.
Publicado: (2022)

Peripapillary Microvascularization Analysis Using Swept-Source Optical Coherence Tomography Angiography in Optic Chiasmal Compression
por: Ben Ghezala, Inès, et al.
Publicado: (2021)

Intraocular Pressure Changes After Intravitreal Fluocinolone Acetonide Implant: Results from Four European Countries
por: Lebrize, Sarah, et al.
Publicado: (2022)

Involvement of Plasmalogens in Post-Natal Retinal Vascular Development
por: Saab, Sarah, et al.
Publicado: (2014)

Association between the retinal vascular network and retinal nerve fiber layer in the elderly: The Montrachet study
por: Arnould, Louis, et al.
Publicado: (2020)

Long-term outcome after topical ciclosporin in severe dry eye disease with a 10-year follow-up
por: Straub, Morgane, et al.
Publicado: (2016)

Plasma fatty acids and primary open-angle glaucoma in the elderly: the Montrachet population-based study
por: Chemaly, Alicia, et al.
Publicado: (2021)

INTRAVITREAL CORTICOSTEROIDS IN DIABETIC MACULAR EDEMA: Pharmacokinetic Considerations
por: Yang, Yit, et al.
Publicado: (2015)

Juvenile X-linked retinoschisis responsive to intravitreal corticosteroids
por: Ansari, Waseem H., et al.
Publicado: (2016)

Intravitreal Anti Vascular Endothelial Growth Factor Agents in The Management of Retinal Diseases: An Audit
por: Fiebai, Bassey, et al.
Publicado: (2017)

Prospective, Observational, Multicenter, Real-World Study of the Efficacy, Safety, and Pattern of Use of the Dexamethasone Intravitreal Implant in Diabetic Macular Edema in France: Short-Term Outcomes of LOUVRE 3
por: Kodjikian, Laurent, et al.
Publicado: (2023)

Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders
por: Hang, Abraham, et al.
Publicado: (2023)

Incidence of new-onset type 1 diabetes during Covid-19 pandemic: A French nationwide population-based study
por: Mariet, Anne-Sophie, et al.
Publicado: (2023)

Did case-based payment influence surgical readmission rates in France? A retrospective study
por: Vuagnat, Albert, et al.
Publicado: (2018)

Intravitreal corticosteroid implant vs intravitreal ranibizumab for the treatment of macular edema: a meta-analysis of randomized controlled trials
por: Wei, Qingquan, et al.
Publicado: (2019)

The Role of Intravitreal Corticosteroids in the Treatment of DME: Predictive OCT Biomarkers
por: Munk, Marion R., et al.
Publicado: (2022)

Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of coats' disease in children
por: Kaul, Shalini, et al.
Publicado: (2010)

Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents
por: Ruão, Miguel, et al.
Publicado: (2017)

Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents
por: Labardini, Cecilia P., et al.
Publicado: (2018)

Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser
por: Gale, Richard, et al.
Publicado: (2021)

Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline
por: Nikkhah, Homayoun, et al.
Publicado: (2018)

Retinal Vascular Density as A Novel Biomarker of Acute Renal Injury after Acute Coronary Syndrome
por: Alan, Guillaume, et al.
Publicado: (2019)

Intravitreal Injections with Vascular Endothelial Growth Factor Inhibitors: A Practical Approach
por: Petri, Anne-Sofie, et al.
Publicado: (2020)

Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
por: Lin, Tzu-Yi, et al.
Publicado: (2023)

Intravitreal Anti-Vascular Endothelial Growth Factor Agents for the Treatment of Diabetic Retinopathy: A Review of the Literature
por: Chatziralli, Irini, et al.
Publicado: (2021)

Intravitreal Anti–Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic
por: Billioti de Gage, Sophie, et al.
Publicado: (2020)

A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema
por: He, Ye, et al.
Publicado: (2018)

National study comparing the incidence of vascular surgical emergencies in France before, during and after the first COVID-19 lockdown in 2020
por: Baudry, Anna, et al.
Publicado: (2022)

Macular Pigment and Open-Angle Glaucoma in the Elderly: The Montrachet Population-Based Study
por: Arnould, Louis, et al.
Publicado: (2022)

Presumed Pyogenic Granuloma Associated with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy
por: Jung, Jesse J, et al.
Publicado: (2011)

Serum Concentration of Vascular Endothelial Growth Factor after Bilateral Intravitreal Injection of Bevacizumab
por: Wang, Donghyun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fqvd3klo4admenqg7pb5rd12nv